Anvyl

Anvyl is a company developing therapies for the treatment of cognitive-deficit disorders and other disorders of the central nervous system (CNS). It creates a pipeline of drugs to fill unmet medical conditions including Alzheimer’s disease, schizophrenia, autism spectrum disorder, Down syndrome, traumatic brain injury, and other CNS disorders such as epilepsy, anxiety, and pain.